Stocks and Investing Stocks and Investing
Wed, July 5, 2017
Mon, July 3, 2017
Fri, June 30, 2017
Thu, June 29, 2017

Christopher Pasquale Initiated (ABT) at Strong Buy and Held Target at $58 on, Jun 29th, 2017


Published on 2024-10-25 21:27:52 - WOPRAI, Christopher Pasquale
  Print publication without navigation
Christopher Pasquale of Guggenheim, Initiated "Abbott Laboratories" (ABT) at Strong Buy and Held Target at $58 on, Jun 29th, 2017.

Christopher has made no other calls on ABT in the last 4 months.



There are 2 other peers that have a rating on ABT. Out of the 2 peers that are also analyzing ABT, all agree with Christopher's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Isaac Ro of "Goldman Sachs" Initiated at Hold and Held Target at $45 on, Tuesday, May 16th, 2017
  • Joanne Wuensch of "BMO Capital" Downgraded from Buy to Hold on, Tuesday, March 14th, 2017
Contributing Sources